Grandville Public Schools and Amazon to Host VEX Robotics Tournament of Champions and Educational Robot Expo
GRANDVILLE, Mich., March 10, 2025 /PRNewswire/ — Saturday, March 15 will be a big day at the Grandville Robotics Competition Center. VEX Robotics event partners... Read more.
CISOs Connect Research Report on Cybersecurity Debt Exposes Widespread Vulnerabilities
Authored by 10 CISOs the Report Explores the Root Causes, Hidden Consequences and How to Mitigate Its Impact NEW YORK, March 10, 2025 /PRNewswire/ — CISOs... Read more.
Ergonomic Claims Cost Businesses Billions Annually
SAN DIEGO, March 10, 2025 /PRNewswire/ — Flexible Assembly Systems today announced that musculoskeletal disorders (MSDs), often caused by poor ergonomics,... Read more.
Pixelworks to Present at the ROTH Annual Conference On March 17
PORTLAND, Ore., March 10, 2025 /PRNewswire/ — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today... Read more.
Sun Pharma to Acquire Checkpoint Therapeutics
Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma... Read more.
SXSW Announces Winners of 2025 Pitch Competition
Seventeenth Annual Competition honors innovative startups within nine categories AUSTIN, Texas, March 9, 2025 /PRNewswire/ — South by Southwest® (SXSW®)... Read more.
HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE
Strategic partnership strengthens regulatory compliance across HashKey Global’s international exchange network. SINGAPORE, March 9, 2025 /PRNewswire/ —... Read more.
Moments That Matter: Insights from Three Million Minutes of Caregiver Support on Trualta’s Platform
Improving outcomes for aging and high-need populations KANSAS CITY, Mo., March 9, 2025 /PRNewswire/ — Trualta, the leading learning and support platform... Read more.
RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
PRINCETON, N.J., March 9, 2025 /PRNewswire/ — RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing... Read more.
Kaname Capital Announces Further Opposition to PROTO Corporation MBO and Introduces Statement by Former Employee
TOKYO–(BUSINESS WIRE)–Kaname Capital (“We,” “Our,” “Us”) submitted an open letter on February 18th with eight questions of concern regarding... Read more.